Pediatric uveitis: a comprehensive review

A Maleki, SD Anesi, S Look-Why, A Manhapra… - Survey of …, 2022 - Elsevier
Abstract Pediatric uveitis accounts for 5–10% of all uveitis. Uveitis in children differs from
adult uveitis in that it is commonly asymptomatic and can become chronic and cause …

[HTML][HTML] Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis

A Heiligenhaus, K Minden, C Tappeiner, H Baus… - Seminars in arthritis and …, 2019 - Elsevier
Background Uveitis in juvenile idiopathic arthritis (JIAU) is frequently associated with the
development of complications and visual loss. Topical corticosteroids are the first line …

2019 American College of Rheumatology/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis–associated uveitis

ST Angeles‐Han, S Ringold, T Beukelman… - Arthritis care & …, 2019 - Wiley Online Library
Objective To develop recommendations for the screening, monitoring, and treatment of
uveitis in children with juvenile idiopathic arthritis (JIA). Methods Pediatric rheumatologists …

New and updated recommendations for the treatment of juvenile idiopathic arthritis–associated uveitis and idiopathic chronic anterior uveitis

I Foeldvari, I Maccora, H Petrushkin… - Arthritis care & …, 2023 - Wiley Online Library
Objective The Multinational Interdisciplinary Working Group for Uveitis in Childhood
identified the need to update the current guidelines, and the objective here was to produce …

[HTML][HTML] Suprachoroidal delivery of small molecules, nanoparticles, gene and cell therapies for ocular diseases

C Wan, L Muya, V Kansara, TA Ciulla - Pharmaceutics, 2021 - mdpi.com
Suprachoroidal drug delivery technology has advanced rapidly and emerged as a promising
administration route for a variety of therapeutic candidates, in order to target multiple ocular …

Suprachoroidally injected pharmacological agents for the treatment of chorio‐retinal diseases: a targeted approach

Z Habot‐Wilner, G Noronha, CC Wykoff - Acta ophthalmologica, 2019 - Wiley Online Library
Delivery of pharmaceuticals to the posterior segment presents challenges that arise from the
anatomy and clearance pharmacokinetics of the eye. Systemic and several local …

Current management of uveitis-associated ocular hypertension and glaucoma

N Kesav, AG Palestine, MY Kahook… - Survey of …, 2020 - Elsevier
Glaucoma secondary to ocular inflammation is potentially blinding and requires aggressive
multifaceted management. The pathogenesis is related to the intraocular pressure elevation …

Improved clinical outcomes in patients with juvenile idiopathic arthritis associated uveitis in the last decade

RAW Wennink, V Kalinina Ayuso… - Acta …, 2022 - Wiley Online Library
Purpose The purpose of the study was to analyse the development of ocular complications
and visual prognosis in juvenile idiopathic arthritis associated uveitis (JIA‐uveitis) compared …

Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohort

G Morelle, J Gueudry, F Uettwiller, C Wouters… - RMD open, 2019 - rmdopen.bmj.com
Objective To evaluate the demographics, aetiologies, complications, treatments and visual
prognoses of chronic and recurrent non-infectious paediatric-onset uveitis in France …

Risk of ocular hypertension in adults with noninfectious uveitis

E Daniel, M Pistilli, S Kothari, N Khachatryan… - Ophthalmology, 2017 - Elsevier
Purpose To describe the risk and risk factors for ocular hypertension (OHT) in adults with
noninfectious uveitis. Design Retrospective, multicenter, cohort study. Participants Patients …